Diabetes, Vol 37, Issue 1 60-64, Copyright © 1988 by American Diabetes Association

ARTICLES

Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening

RR Little, JD England, HM Wiedmeyer, EM McKenzie, DJ Pettitt, WC Knowler and DE Goldstein
Department of Pathology, University of Missouri School of Medicine, Columbia 65212.

The oral glucose tolerance test (OGTT) for diagnosis of diabetes is inconvenient and requires a great deal of patient cooperation. Glycosylated hemoglobin (GHb), an index of long-term glycemic control, could offer several practical advantages over the OGTT for diabetes screening. We evaluated GHb as a screen for diabetes in 381 adults from a population with a high prevalence of non-insulin-dependent diabetes (Pima Indians). All individuals underwent a standard OGTT (75 g) and were separated into one of three groups: normal (N), impaired glucose tolerance (IGT), or diabetes mellitus (D) based on World Health Organization criteria. HbA1c, a GHb, was measured by highly precise high-performance liquid chromatography (interassay C.V. less than 4%). The normal range for HbA1c was 4.07-6.03% based on the 95% confidence interval for a nondiabetic, mostly Caucasian population. Compared with OGTT, HbA1c was highly specific (91%); an elevated HbA1c usually indicated D or IGT (sensitivity = 85 and 30%, respectively). A normal HbA1c did not, however, exclude a diagnosis of D or IGT. Based on previous epidemiological studies relating plasma glucose to chronic diabetic complications, GHb as measured in this study would properly identify the vast majority of subjects at risk. Long-term studies are necessary to determine the actual risk of complications in individuals with persistently normal HbA1c and D or IGT (based on OGTT).
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Eldeirawi and R. B. Lipton Predictors of Hemoglobin A1c in a National Sample of Nondiabetic Children: The Third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Epidemiol., April 1, 2003; 157(7): 624 - 632. [Abstract] [Full Text] [PDF]

				Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care, January 1, 2003; 26(90001): s5 - 20. [Full Text] [PDF]

				S. H. Saydah, D. Byrd-Holt, and M. I. Harris Projected Impact of Implementing the Results of the Diabetes Prevention Program in the U.S. Population Diabetes Care, November 1, 2002; 25(11): 1940 - 1945. [Abstract] [Full Text] [PDF]

				M. P. Stern, K. Williams, and S. M. Haffner Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? Ann Intern Med, April 16, 2002; 136(8): 575 - 581. [Abstract] [Full Text] [PDF]

				C. Levetan and M. Sharma Case Study: The Recipe for Diabetes Success in the Hospital Diabetes Spectr, January 1, 2002; 15(1): 40 - 43. [Full Text] [PDF]

				J. R. Singleton, A. G. Smith, and M. B. Bromberg Increased Prevalence of Impaired Glucose Tolerance in Patients With Painful Sensory Neuropathy Diabetes Care, August 1, 2001; 24(8): 1448 - 1453. [Abstract] [Full Text] [PDF]

				R. C. Perry, R. R. Shankar, N. Fineberg, J. McGill, and A. D. Baron HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose: The Early Diabetes Intervention Program (EDIP) Diabetes Care, March 1, 2001; 24(3): 465 - 471. [Abstract] [Full Text]